Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Nitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhage.

Kim H, Britton GL, Peng T, Holland CK, McPherson DD, Huang SL.

Int J Nanomedicine. 2014;9:155-65. doi: 10.2147/IJN.S48856.

2.

Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia.

Huang SL, Kee PH, Kim H, Moody MR, Chrzanowski SM, Macdonald RC, McPherson DD.

J Am Coll Cardiol. 2009 Aug 11;54(7):652-9. doi: 10.1016/j.jacc.2009.04.039.

3.

Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage.

Momin EN, Schwab KE, Chaichana KL, Miller-Lotan R, Levy AP, Tamargo RJ.

Neurosurgery. 2009 Nov;65(5):937-45; discussion 945. doi: 10.1227/01.NEU.0000356974.14230.B8.

PMID:
19834407
4.

Prevention and reversal of experimental posthemorrhagic vasospasm by the periadventitial administration of nitric oxide from a controlled-release polymer.

Tierney TS, Clatterbuck RE, Lawson C, Thai QA, Rhines LD, Tamargo RJ.

Neurosurgery. 2001 Oct;49(4):945-51; discussion 951-3.

PMID:
11564257
5.

The role of nitric oxide donors in treating cerebral vasospasm after subarachnoid hemorrhage.

Fathi AR, Bakhtian KD, Pluta RM.

Acta Neurochir Suppl. 2011;110(Pt 1):93-7. doi: 10.1007/978-3-7091-0353-1_17. Review.

PMID:
21116922
6.

The effect of thiocolchicoside on cerebral vasospasm following experimental subarachnoid hemorrhage in the rabbit.

Kertmen H, Gürer B, Yilmaz ER, Arikok AT, Demirci A, Gökyaprak SM, Sekerci Z.

Acta Neurochir (Wien). 2012 Aug;154(8):1431-6. doi: 10.1007/s00701-012-1420-3.

PMID:
22722379
7.

Nitric oxide improves molecular imaging of inflammatory atheroma using targeted echogenic immunoliposomes.

Kim H, Kee PH, Rim Y, Moody MR, Klegerman ME, Vela D, Huang SL, McPherson DD, Laing ST.

Atherosclerosis. 2013 Dec;231(2):252-60. doi: 10.1016/j.atherosclerosis.2013.09.026.

8.

Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage.

Echigo R, Shimohata N, Karatsu K, Yano F, Kayasuga-Kariya Y, Fujisawa A, Ohto T, Kita Y, Nakamura M, Suzuki S, Mochizuki M, Shimizu T, Chung UI, Sasaki N.

J Transl Med. 2012 Apr 30;10:80. doi: 10.1186/1479-5876-10-80.

10.

Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion.

Hänggi D, Turowski B, Beseoglu K, Yong M, Steiger HJ.

AJNR Am J Neuroradiol. 2008 Jun;29(6):1053-60. doi: 10.3174/ajnr.A1005.

11.

Continuous intrathecal glyceryl trinitrate prevents delayed cerebral vasospasm in the single-SAH rabbit model in vivo.

Fathi AR, Marbacher S, Graupner T, Wehrli F, Jakob SM, Schroth G, Fandino J.

Acta Neurochir (Wien). 2011 Aug;153(8):1669-75; discussion 1675. doi: 10.1007/s00701-011-1049-7.

PMID:
21671141
12.

Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.

Bele S, Proescholdt MA, Hochreiter A, Schuierer G, Scheitzach J, Wendl C, Kieninger M, Schneiker A, Bründl E, Schödel P, Schebesch KM, Brawanski A.

Acta Neurochir (Wien). 2015 Dec;157(12):2041-50. doi: 10.1007/s00701-015-2597-z.

PMID:
26439105
13.

Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes.

Smith DA, Vaidya SS, Kopechek JA, Huang SL, Klegerman ME, McPherson DD, Holland CK.

Ultrasound Med Biol. 2010 Jan;36(1):145-57. doi: 10.1016/j.ultrasmedbio.2009.08.009.

14.

Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.

Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V.

J Neurosurg. 2016 Jan;124(1):51-8. doi: 10.3171/2014.12.JNS13846.

PMID:
26162034
15.

Attenuation of cerebral vasospasm and secondary injury by testosterone following experimental subarachnoid hemorrhage in rabbit.

Gürer B, Turkoglu E, Kertmen H, Karavelioglu E, Arikok AT, Sekerci Z.

Acta Neurochir (Wien). 2014 Nov;156(11):2111-20; discussion 2120. doi: 10.1007/s00701-014-2211-9.

PMID:
25194970
16.

Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin.

Ito Y, Isotani E, Mizuno Y, Azuma H, Hirakawa K.

J Cardiovasc Pharmacol. 2000 Jan;35(1):45-50.

PMID:
10630732
17.

Cost-effectiveness of CT angiography and perfusion imaging for delayed cerebral ischemia and vasospasm in aneurysmal subarachnoid hemorrhage.

Sanelli PC, Pandya A, Segal AZ, Gupta A, Hurtado-Rua S, Ivanidze J, Kesavabhotla K, Mir D, Mushlin AI, Hunink MG.

AJNR Am J Neuroradiol. 2014 Sep;35(9):1714-20. doi: 10.3174/ajnr.A3947.

18.

Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.

Matsuda N, Ohkuma H, Naraoka M, Munakata A, Shimamura N, Asano K.

J Neurosurg. 2014 Sep;121(3):621-30. doi: 10.3171/2014.5.JNS132140.

PMID:
24949677
19.

The effect of an adenosine A1 receptor agonist in the treatment of experimental subarachnoid hemorrhage-induced cerebrovasospasm.

Lin CL, Su YF, Dumont AS, Shih HC, Lieu AS, Howng SL, Lee KS, Kwan AL.

Acta Neurochir (Wien). 2006 Aug;148(8):873-9; discussion 879.

PMID:
16791438
20.

Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm.

Ehtisham A, Taylor S, Bayless L, Samuels OB, Klein MW, Janzen JM.

South Med J. 2009 Feb;102(2):150-3. doi: 10.1097/SMJ.0b013e31818f8ba4.

PMID:
19139684

Supplemental Content

Support Center